B. Lecoester

Response to Chemoimmunotherapy Is Associated With Expansion of Systemic Antitumor CD4+ Th1 Response in Metastatic Non–Small Cell Lung Cancer

Abhishek Kumar, Abhishek Kumar, O. Adotévi, 2023, Journal of immunotherapy.

Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma

F. Ghiringhelli, P. Saas, B. Gaugler, 2022, Cancer Immunology, Immunotherapy.

TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition

Abhishek Kumar, Abhishek Kumar, F. Aubin, 2022, Frontiers in Immunology.

Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy

R. Boidot, J. Pallandre, A. Kirilovsky, 2021, Journal for ImmunoTherapy of Cancer.

Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies

C. Mirjolet, G. Truc, O. Adotévi, 2021, Cancers.

Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood

S. Servagi, C. Mirjolet, O. Adotévi, 2021, BMC immunology.

Contribution of chemotherapy in immunoradiotherapy combinations.

J. Boustani, Y. Xie, B. Lecoester, 2023, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.